Samsung Biologics
207940.KS
#505
Rank
โ‚ฌ43.69 B
Marketcap
944,01ย โ‚ฌ
Share price
-1.02%
Change (1 day)
49.09%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2026 (TTM): 21,33ย โ‚ฌ

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is 21,12ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 15,97ย โ‚ฌ an increase over its 2024 EPS that were of 8,95ย โ‚ฌ.

EPS history for Samsung Biologics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)21,33ย โ‚ฌ33.53%
202515,97ย โ‚ฌ78.53%
20248,95ย โ‚ฌ11.34%
20238,04ย โ‚ฌ2.67%
20227,83ย โ‚ฌ83.43%
20214,27ย โ‚ฌ49.14%
20202,86ย โ‚ฌ26.39%
20192,26ย โ‚ฌ-12.58%
20182,59ย โ‚ฌ-320.64%
2017-1,17ย โ‚ฌ-46.78%
2016-2,21ย โ‚ฌ-105.09%
201543,35ย โ‚ฌ-1089.67%
2014-4,38ย โ‚ฌ